Patents by Inventor Jayhong A. Chong

Jayhong A. Chong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating pain
    Patent number: 8541423
    Abstract: The present application relates to compounds and methods for treating pain, incontinence and other conditions.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: September 24, 2013
    Assignee: Hydra Biosciences, Inc.
    Inventors: Magdalene M. Moran, Christopher Fanger, Jayhong A. Chong, Colleen McNamara, Xiaoguang Zhen, Josh Mandel-Brehm
  • COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES
    Publication number: 20130165427
    Abstract: Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein.
    Type: Application
    Filed: August 24, 2012
    Publication date: June 27, 2013
    Applicant: HYDRA BIOSCIENCES, INC.
    Inventor: Jayhong A. Chong
  • METHODS AND COMPOSTIONS FOR TREATING PAIN
    Publication number: 20130123283
    Abstract: The present application relates to compounds and methods for treating pain, incontinence and other conditions.
    Type: Application
    Filed: April 11, 2012
    Publication date: May 16, 2013
    Inventors: Magdalene M. Moran, Christopher Fanger, Jayhong A. Chong, Colleen McNamara, Xiaoguang Zhen, Josh Mendel-Brehm
  • SPERM-SPECIFIC CATION CHANNEL, CATSPER3, AND USES THEREFOR
    Publication number: 20130072403
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: January 30, 2012
    Publication date: March 21, 2013
    Applicant: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian Scott Ramsey, David E. Clapham
  • SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR
    Publication number: 20130067603
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: February 10, 2012
    Publication date: March 14, 2013
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian Scott Ramsey, David E. Clapham
  • Modulators of sperm hypermotility and uses thereof
    Patent number: 8394840
    Abstract: The invention provides novel compositions and compounds that inhibit CatSper channel activity, that preferentially inhibits sperm hyperactivity over sperm motility, or both. The compounds of the invention are useful as contraceptive agents that may be adminstered to males, females, or concurrently to both sexual partners. The invention further provides methods of conducting drug discovery business and of conducting a reproductive medicine business. The invention also provides methods of identifying compounds that modulate sperm hypermotility.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: March 12, 2013
    Assignee: Hydra Biosciences, Inc.
    Inventors: Jayhong A. Chong, Magdalene M. Moran
  • METHODS AND COMPOSITIONS FOR TREATING DISORDERS
    Publication number: 20130059869
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Application
    Filed: February 22, 2012
    Publication date: March 7, 2013
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • Compounds for modulating TRPV3 function
    Patent number: 8389546
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: March 5, 2013
    Assignee: Hydra Biosciences, Inc.
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Christopher Fanger, Amy Ripka, Glenn R. Larsen, Xiaoguang Zhen, Dennis John Underwood, Manfred Weigele
  • Methods and compositions for treating asthma
    Patent number: 8389529
    Abstract: The present application relates to compounds and methods for treating pain, incontinence and other conditions.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: March 5, 2013
    Assignee: Hydra Biosciences, Inc.
    Inventors: Magdalene M. Moran, Christopher Fanger, Jayhong A. Chong, Colleen McNamara, Xiaoguang Zhen, Josh Mandel-Brehm
  • Compounds and compositions for treating chemical warfare agent-induced injuries
    Patent number: 8318728
    Abstract: Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: November 27, 2012
    Assignee: Hydra Biosciences, Inc.
    Inventor: Jayhong A. Chong
  • VOLTAGE-GATED PROTON CHANNEL, Hv1, AND USES THEREFOR
    Publication number: 20120270236
    Abstract: Nucleic acid and protein sequences relating to a proton channel (HvI) are disclosed. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the HvI gene and protein are disclosed. Also provided are methods of identifying modulators of HvI activity, methods of geno typing subjects with respect to HvI, and methods of diagnosing and treating HvI-mediated disorders.
    Type: Application
    Filed: February 15, 2007
    Publication date: October 25, 2012
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Ian S. Ramsey, Magdalene M. Moran, Jayhong A. Chong, David Clapham
  • Methods and compositions for treating pain
    Patent number: 8178542
    Abstract: The present application relates to compounds and methods for treating pain, incontinence and other conditions.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: May 15, 2012
    Assignee: Hydra Biosciences, Inc.
    Inventors: Magdalene M. Moran, Christopher Fanger, Jayhong A. Chong, Colleen McNamara, Xiaoguang Zhen, Josh Mandel-Brehm
  • COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES
    Publication number: 20120108614
    Abstract: Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein.
    Type: Application
    Filed: May 14, 2009
    Publication date: May 3, 2012
    Inventor: Jayhong A. Chong
  • COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES
    Publication number: 20120108613
    Abstract: Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein.
    Type: Application
    Filed: May 14, 2009
    Publication date: May 3, 2012
    Inventor: Jayhong A. Chong
  • Methods and compositions for treating disorders
    Patent number: 8163761
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: April 24, 2012
    Assignee: Hydra Biosciences, Inc.
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • Sperm-specific cation channel, CatSper4, and uses therefor
    Patent number: 8137918
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: March 20, 2012
    Assignee: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian S. Ramsey, David Clapham
  • Sperm-specific cation channel, catsper-3 and uses therefor
    Patent number: 8110668
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Grant
    Filed: August 4, 2003
    Date of Patent: February 7, 2012
    Assignee: Children's Medical Center Corporation
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Ian Scott Ramsey, David E. Clapham
  • Compounds for Modulating TRPV3 Function
    Publication number: 20120015979
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: July 1, 2011
    Publication date: January 19, 2012
    Applicant: Hydra Biosciences, Inc,
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Christopher Fanger, Amy Ripka, Glenn R. Larsen, Xiaoguang Zhen, Dennis John Underwood, Manfred Weigele
  • METHODS AND COMPOSITIONS FOR TREATING ANXIETY
    Publication number: 20110319417
    Abstract: Methods of treating a TRPC5 mediated disorder in a subject by administering an effective amount of a TRPC5 antagonist, such as a compound disclosed herein, are described.
    Type: Application
    Filed: August 6, 2009
    Publication date: December 29, 2011
    Inventors: Jayhong Chong, Christopher Fanger, Magdalene M. Moran, Elisha Singer, Timothy Strassmaier, Howard Ng
  • Compounds for modulating TRPV3 function
    Patent number: 7998980
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: August 16, 2011
    Assignee: Hydra Biosciences, Inc.
    Inventors: Magdalene M. Moran, Jayhong A. Chong, Christopher Fanger, Amy Ripka, Glenn R. Larsen, Xiaoguang Zhen, Dennis John Underwood, Manfred Weigele